Skip to main content
. 2016 Nov 29;8(2):2466–2476. doi: 10.18632/oncotarget.13690

Figure 4. Effect of FOXO4 on the expression of target proteins in phenylbutyrate treated-surviving cells.

Figure 4

(A, B) Phenylbutyrate-treated surviving cells (BJAB-PB and Raji-PB) increase the expression of FOXO4 and its transcriptional targets (p21, p27, and SOD) compared to control cells. (C, D) BJAB-PB and Raji-PB cells show decreased expression of cyclin D1, CDK4, and cyclin A compared to control cells.